BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37753112)

  • 1. Elevation of serum human epididymis protein 4 (HE4) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) as predicting factors for the occurrence of acute kidney injury on chronic kidney disease: a single-center retrospective self-control study.
    Song J; Chen L; Yuan Z; Gong X
    Front Pharmacol; 2023; 14():1269311. PubMed ID: 37753112
    [No Abstract]   [Full Text] [Related]  

  • 2. The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.
    Fu S; Luo L; Ye P; Yi S; Liu Y; Zhu B; Wang L; Xiao T; Bai Y
    Clin Interv Aging; 2013; 8():409-17. PubMed ID: 23723693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population.
    Tan S; Zeng Y; Kuang S; Li J
    Diabetes Metab Syndr Obes; 2021; 14():1601-1608. PubMed ID: 33889001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
    Bansal N; Zelnick LR; Ballantyne CM; Chaves PHM; Christenson RH; Coresh J; deFilippi CR; de Lemos JA; Daniels LB; Go AS; He J; Hedayati SS; Matsushita K; Nambi V; Shlipak MG; Taliercio JJ; Seliger SL;
    Am J Kidney Dis; 2022 Mar; 79(3):383-392. PubMed ID: 34293394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.
    Lin KY; Wu ZY; You ZB; Zheng WP; Lin CJ; Jiang H; Ruan JM; Guo YS; Zhu PL
    Int Heart J; 2018 Sep; 59(5):926-934. PubMed ID: 30158378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
    Naruse H; Ishii J; Takahashi H; Kitagawa F; Nishimura H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Hayashi M; Sarai M; Watanabe E; Izawa H; Ozaki Y
    Crit Care; 2018 Aug; 22(1):197. PubMed ID: 30119691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.
    Wang K; Li HL; Chen LL; Bei WJ; Lin KY; Smyth B; Chen SQ; Guo XS; Guo W; Liu YH; Chen PY; Chen JY; Chen KH; Liu Y; Tan N
    Medicine (Baltimore); 2017 Mar; 96(10):e6259. PubMed ID: 28272231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit].
    Li H; Wang H; Lou Y; Miao W; Sha N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):508-12. PubMed ID: 25027431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial.
    Chen L; Gong X
    Evid Based Complement Alternat Med; 2022; 2022():1099642. PubMed ID: 35341156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative N-terminal pro-B-type natriuretic peptide for prediction of acute kidney injury after noncardiac surgery: A retrospective cohort study.
    Zhao BC; Zhuang PP; Lei SH; Qiu SD; Yang X; Li C; Liu WF; Liu KX
    Eur J Anaesthesiol; 2021 Jun; 38(6):591-599. PubMed ID: 33720062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum N-terminal pro-brain natriuretic peptide levels with survival and renal outcomes among elderly patients with acute kidney injury in chronic heart failure.
    Hou J; Zhang X; Wu Z; Liu Y; Zhang Y; Zhao J; Wang X; Chen H; Yang G; Ma Q; Cheng Q; Ao Q
    Front Cardiovasc Med; 2023; 10():1104787. PubMed ID: 36818349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial.
    Chen L; Ye Z; Wang D; Liu J; Wang Q; Wang C; Xu B; Gong X
    Front Pharmacol; 2022; 13():969107. PubMed ID: 36263137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure].
    Menzorov MV; Shutov AM; Midlenko VI; Larionova NV; Morozova IV; Akulova OV
    Ter Arkh; 2017; 89(3):78-84. PubMed ID: 28378735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum N-terminal pro-B-type natriuretic peptide and cystatin C for acute kidney injury detection in critically ill adults in China: a prospective, observational study.
    Deng J; He L; Liang Y; Hu L; Xu J; Fang H; Li Y; Chen C
    BMJ Open; 2023 Jan; 13(1):e063896. PubMed ID: 36717146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
    Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
    J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cardiac biomarkers on risk assessment of contrast-associated acute kidney injury in patients undergoing cardiac catheterization: A multicenter retrospective study.
    Yu S; Li Q; He Y; Jia C; Liang G; Lu H; Wu W; Liu J; Liu Y; Chen J
    Nephrology (Carlton); 2023 Nov; 28(11):588-596. PubMed ID: 37619965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.